Computer Aided Diagnosis of Clinically Significant Prostate Cancer in Low-Risk Patients on Multi-Parametric MR Images Using Deep Learning

The purpose of this study was to develop a quantitative method for detection and segmentation of clinically significant (ISUP grade ≥ 2) prostate cancer (PCa) in low-risk patient. A consecutive cohort of 356 patients (active surveillance) was selected and divided in two groups: 1) MRI and targeted-biopsy positive PCa, 2) MRI and standard-biopsy negative PCa. A 3D convolutional neural network was trained in three-fold cross validation with MRI and targeted-biopsy positive patient's data using two mp-MRI sequences (T2-weighted, DWI-b800) and ADC map as input. After training, the model was tested on separate positive and negative patients to evaluate the performance. The model achieved an average area under the curve (AUC) of the receiver operating characteristics is 0.78 (sensitivity = 85%, specificity = 72%). The diagnostic performance of the proposed method in segmenting significant PCa and to conform non-significant PCa in low-risk patients is characterized by a good AUC and negative-predictive-value.

[1]  C. Zuiani,et al.  Interreader agreement of PI‐RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole‐mount histology as the standard of reference , 2018, Journal of magnetic resonance imaging : JMRI.

[2]  Tobias Penzkofer,et al.  Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network , 2019, European Radiology.

[3]  Ewout W Steyerberg,et al.  Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. , 2019, The Cochrane database of systematic reviews.

[4]  А. С. Коробкин,et al.  Информативность мультипараметрического МР-исследования в выявлении рака предстательной железы. Классификация pi-rads (prostate imaging-reporting and data system) , 2015 .

[5]  Anant Madabhushi,et al.  Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings , 2018, Journal of magnetic resonance imaging : JMRI.

[6]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[7]  Stuart A. Taylor,et al.  “Textural analysis of multiparametric MRI detects transition zone prostate cancer” , 2016, European Radiology.

[8]  Muhammad Arif,et al.  Automatic needle detection and real‐time Bi‐planar needle visualization during 3D ultrasound scanning of the liver , 2019, Medical Image Anal..

[9]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[10]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[11]  D. Nieboer,et al.  Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. , 2015, European urology.

[12]  R. V. D. van den Bergh,et al.  Prospective validation of active surveillance in prostate cancer: the PRIAS study. , 2007, European urology.

[13]  Pierre Mozer,et al.  Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. , 2015, European urology.

[14]  Nathan Lay,et al.  Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks , 2018, Journal of medical imaging.

[15]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.